Piramal Pharma Solutions Boosts Peptide Capabilities with Spray Drying Suite in India
Event summary
- Piramal Pharma Solutions added a spray drying suite with Band 5 containment at its Turbhe, India facility on August 4, 2026.
- The new suite supports formulation of peptides, HPAPIs, and other biomolecules with ISO Class 8 cleanliness standards.
- The system handles up to 1 liter per hour feed rate and processes solutions with up to 30% water content.
- Dr. Jordi Bacardit, Global Technical Lead on Peptides at PPS, highlighted the suite's ability to address peptide instability challenges.
The big picture
This expansion positions Piramal Pharma Solutions to better serve the growing demand for peptide-based therapeutics, a key segment in modern pharmaceutical development. The investment in advanced formulation technology comes as CDMOs face increasing pressure to handle complex, temperature-sensitive molecules while maintaining regulatory compliance and operational efficiency.
What we're watching
- Capacity Utilization
- How quickly Piramal Pharma Solutions fills the new spray drying suite with peptide formulation projects.
- Competitive Positioning
- Whether this expansion strengthens PPS's market share in complex molecule CDMO services.
- Technological Adoption
- The pace at which pharmaceutical partners adopt this advanced spray drying capability for their peptide development programs.